Clinical Trials Logo

Anterior Blepharitis clinical trials

View clinical trials related to Anterior Blepharitis.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05160623 Recruiting - Clinical trials for Anterior Blepharitis

Treatment of Blepharitis With Povidone-Iodine 1%

Start date: August 16, 2021
Phase: N/A
Study type: Interventional

One hundred blepharitis patients will be recruited. Each patient will treat one eye once daily with 1% PVI for 30 days by scrubbing the eyelid margin with the solution. The fellow eye will serve as the control and be given the standard treatment (commercial eye wipes). Before treatment initiation, various ocular surface variables will be assessed, such as dry eye grading, subjective discomfort scales, ocular surface questionnaire, and other clinical signs. After 30 days, an identical evaluation will be performed.